Welcome to our dedicated page for CYABRA SEC filings (Ticker: CYAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CYABRA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CYABRA's regulatory disclosures and financial reporting.
Cyabra, Inc. director and Chief Product Officer Yossef Daar filed a Schedule 13D reporting a 5.1% beneficial ownership stake in the company’s common stock. He holds 710,549 shares, including stock received in Cyabra’s business combination and fully vested restricted stock units, and is subject to a nine‑month lock-up on sales.
Cyabra, Inc. Chief Executive Officer Dan Brahmy filed a Schedule 13D disclosing beneficial ownership of 711,548 shares of common stock, representing 5.1% of Cyabra’s outstanding shares as of March 27, 2026. This stake arose from Cyabra’s business combination with Trailblazer Merger Corporation I and related equity awards.
The holdings include 535,402 shares held in trust, 134,000 fully vested restricted stock units granted for his service as CEO and director, and options for 42,146 shares exercisable at $0.0009 per share, expiring on November 13, 2033. Under a Lock-Up Agreement, Brahmy agreed not to sell or hedge these securities for nine months from March 27, 2026, limiting his ability to dispose of shares in the near term while he evaluates his investment on an ongoing basis.
Cyabra, Inc.'s Chief Technology Officer, Ido Shraga, reports beneficial ownership of 710,549 shares of common stock, or 5.1% of Cyabra, Inc. (CYAB). His stake reflects shares received in a business combination between Trailblazer entities and Cyabra Strategy Ltd., plus a fully vested equity grant.
Most of his position comes from 577,549 shares of common stock issued in exchange for 160,000 Cyabra ordinary shares at the merger’s effective time. He also holds 133,000 shares underlying restricted stock units granted for his CTO service. A lock-up agreement restricts sales or hedging of these securities for nine months from March 27, 2026.
Cyabra, Inc. ownership disclosure: Lowenstein Sandler LLP reported beneficial ownership of 1,000,000 shares of Cyabra common stock as of March 27, 2026. The filing states this equals approximately 7.2% of the 13,814,167 shares outstanding reported to the reporting person on that date.
The reporting person reports sole voting and sole dispositive power over the 1,000,000 shares. The Schedule 13G is signed by David Wissert as General Counsel on April 1, 2026.
CYABRA, INC. Chief Product Officer Yossef Daar indirectly acquired common stock in connection with the company’s business combination and a new equity award. At the effective time of the Business Combination, 160,000 ordinary shares of Cyabra held for him were converted into 577,549 shares of the issuer’s common stock, held by IBI Trust Management in trust.
On March 27, 2026, he was also granted 133,000 restricted stock units under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, fully vested upon grant and effective 30 days after the 2026 Israeli Sub-Plan is filed with the Israel Tax Authority. Following these acquisitions, his indirect holdings reported in this filing total 710,549 shares.
CYABRA, INC. Chief Revenue Officer Emmanuel Heymann received two stock option awards tied to the company’s recent business combination. He was granted options over 25,264 shares of common stock at a $1.00 exercise price and options over 28,883 shares at a $7.53 exercise price, both expiring on February 19, 2033.
These options replace prior Cyabra Strategy Ltd. options under the Cyabra, Inc. 2026 Omnibus Incentive Plan. The January 2023 Replacement Option and January 2025 Replacement Option each vest over three years and ten months, with 25% vesting 10 months after their respective January 1 vesting commencement dates and the remainder vesting in equal monthly installments.
CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination. The award covers options to buy 14,436 shares of common stock at an exercise price of $1.00 per share, expiring on January 8, 2035.
According to the footnotes, this option replaces a prior Cyabra Strategy Ltd. option for 4,000 ordinary shares under the merger agreement with Trailblazer Merger Corporation I. After this grant, Madon holds options covering 14,436 shares, reflecting compensation and equity alignment following the transaction.
This Form 3 identifies Dan Brahmy, Chief Executive Officer and director of Cyabra, Inc., as a reporting person and insider of the company. The provided data shows no reported share transactions or derivative positions, functioning as an initial status disclosure rather than a trading report.
CYABRA, INC. director and Chief Product Officer Yossef Daar has filed an initial statement of beneficial ownership on Form 3. This filing identifies him as both a director and officer of CYABRA, INC. but does not report any specific share transactions or detailed holdings in the provided data.
CYABRA, INC. director Michael Pompeo filed an initial Form 3 as a reporting person for the company. The filing lists him as a director and indicates no reportable transactions or derivative positions at this time, establishing his insider status under SEC rules.